Cargando…
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids
Tumor organoids maintain cell–cell interactions, heterogeneity, microenvironment, and drug response of the sample they originate from. Thus, there is increasing interest in developing tumor organoid models for drug development and personalized medicine applications. Although organoids are in princip...
Autores principales: | Phan, Nhan, Hong, Jenny J., Tofig, Bobby, Mapua, Matthew, Elashoff, David, Moatamed, Neda A., Huang, Jin, Memarzadeh, Sanaz, Damoiseaux, Robert, Soragni, Alice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389967/ https://www.ncbi.nlm.nih.gov/pubmed/30820473 http://dx.doi.org/10.1038/s42003-019-0305-x |
Ejemplares similares
-
Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening
por: Nguyen, Huyen Thi Lam, et al.
Publicado: (2020) -
Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
por: Singh, Tanya, et al.
Publicado: (2020) -
A rare case of vulvar extraskeletal myxoid chondrosarcoma: mimics and diagnostic clues
por: Liou, Sofia S., et al.
Publicado: (2021) -
Efficacy of birinapant in combination with carboplatin in targeting platinum-resistant epithelial ovarian cancers
por: Singh, Tanya, et al.
Publicado: (2022) -
Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors
por: Samiei, Alireza, et al.
Publicado: (2022)